Logo
   
List Profile
Project name Industry Sub Sector Revenue EBITDA Geography Deal Type Matches
Window & Door Manufacturer Manufacturing
- Building Products
- Construction Materials
$20.3M $4.4M United States of America
Corporate Seller 2 matches
Cancer Prevention Pharma Co. w/50% Cash Flow Margin Healthcare
- Health Care Distributors
- Health Care Equipment
- Health Care Services
- Health Care Supplies
- Health Care Technology
$5.7M $3M United States of America
Corporate Seller 2 matches
Retail & eCommerce -- Acquisition Financing - Consumer Goods
- Energy & Utilities
- Housewares & Specialities
- Food, Beverage & Tobacco
- Agricultural Products
- Brewers
- Distillers & Vintners
- Soft Drinks
- Household & Personal Products
- Household Products
- Alternative Energy
- Alternative Energy Distribution
- Alternative Energy Production
- Energy Equipment & Services
- Oil & Gas Drilling
- Oil & Gas Equipment & Services
- Oil, Gas & Consumable Fuels
- Coal & Consumable Fuels
- Integrated Oil & Gas
- Oil & Gas Exploration & Production
- Oil & Gas Refining & Marketing
- Oil & Gas Storage & Transportation
- Utilities
- Electric Utilities
- Gas Utilities
- Independant Power Producers & Energy Traders
- Multi-Utilities
- Water Utilities
$17M $4M - Western Europe
- United States of America
Capital Seeker 6 matches
$20M+ Revenue eCommerce Business Consumer Goods
- Automotive Products
- Auto Parts & Accessories
- Tires & Rubber
- Consumer Durables & Apparel
- Apparel, Accessories & Luxury Goods
- Consumer Electronics
- Footwear
- Home Furnishings
- Household Appliances
- Housewares & Specialities
- Leisure Products
- Photographic Products
- Textiles
- Agricultural Products
- Packaged Foods & Meats
- Household & Personal Products
- Household Products
- Personal Products
$20M $0.7M United States of America
Corporate Seller 2 matches

Corporate Seller#COS201823

Card image cap

Project Name

Window & Door Manufacturer

Revenue

$20.3M

EBITDA

$4.4M

Industry

Manufacturing

Location

United States of America

Corporate Seller#COS201822

Card image cap

Project Name

Cancer Prevention Pharma Co. w/50% Cash Flow Margin

Revenue

$5.7M

EBITDA

$3M

Industry

Healthcare

Location

United States of America

Capital Seeker#CS201848

Card image cap

Project Name

Retail & eCommerce -- Acquisition Financing

Revenue

$17M

EBITDA

$4M

Industry

- Consumer Goods
- Energy & Utilities

Location

- Western Europe
- United States of America

Corporate Seller#COS201821

Card image cap

Project Name

$20M+ Revenue eCommerce Business

Revenue

$20M

EBITDA

$0.7M

Industry

Consumer Goods

Location

United States of America

This page shows above 1200 resolution

© Copyright Deal Capital Partners, LLC

Securities transactions are conducted through Reliance Worldwide Investments, LLC ("RWI"), a member of FINRA and SIPC. RWI assumes no responsibility, or liability, for the contents of this website or any linked site(s); nor should it be presumed to be RWI's view or an implied endorsement. Check the background of this Broker-Dealer and its registered investment professionals on FINRA's BrokerCheck.

Privacy Policy | Terms of Service | Listing Agreement

This does not constitute an offer to sell or a solicitation of an offer to buy any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of a final private placement offering memorandum and subscription agreement, and will be subject to the terms and conditions and risks delivered in such documents.

Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a sell-side offering memorandum, subscription agreement and/or private placement memorandum ("the Documents"). Before making an investment decision with respect to any investment described herein, potential investors are advised to carefully review the Documents. Any investment overview found on the InvestmentBank.com platform is intended only as a preliminary, confidential summary of such investment. This summary does not purport to be complete and is qualified in its entirety by reference to the more detailed discussion contained in the actual text of the Documents.

Before Documents are delivered to investors directly or indirectly, investors may be subject to third-party accredited investor verification checks as well as verification for requisite know your customer (KYC) and anti-money laundering (AML) laws. Deal Capital Partners, LLC relies on third party groups to perform such checks and is not liable for the accuracy of determining investor status at the time of any Document delivery.

All investors should make their own determination of whether or not to make any investment based on their own independent evaluation and analysis. Deal Capital Partners, LLC does not verify or assure that information provided by any listed company offering its securities is accurate or complete or that the valuation of such securities is appropriate. Neither Deal Capital Partners, LLC nor any of its directors, officers, employees, representatives, affiliates or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation of, any accredited investor verification or of any of the materials posted on this website. Deal Capital Partners, LLC does not provide legal, accounting or tax advice. Any representation or implication to the contrary is expressly disclaimed.